CN Patent

CN101346473A — 用于在具有补体因子h的风险变体的患者中预防和治疗年龄相关性黄斑变性的c3-转化酶抑制剂

Assigned to Alcon Research LLC · Expires 2009-01-14 · 17y expired

What this patent protects

本发明提供了通过鉴定补体因子H基因中的Y402H多态或其它风险变体的存在，用于鉴定处于发生AMD的风险下的患者的方法。本发明还提供了治疗下述人的方法，所述人由于补体因子H基因中具有Y402H多态或其它风险变体而患有AMD或处于发生AMD的风险下。

USPTO Abstract

本发明提供了通过鉴定补体因子H基因中的Y402H多态或其它风险变体的存在，用于鉴定处于发生AMD的风险下的患者的方法。本发明还提供了治疗下述人的方法，所述人由于补体因子H基因中具有Y402H多态或其它风险变体而患有AMD或处于发生AMD的风险下。

Drugs covered by this patent

Patent Metadata

Patent number: CN101346473A
Jurisdiction: CN
Classification: —
Expires: 2009-01-14
Drug substance claim: No
Drug product claim: No
Assignee: Alcon Research LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.